| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/24/2008 | WO2008156160A1 Composition for transdermal or transmucosal administration |
| 12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 12/24/2008 | WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156069A1 Screening method for antibody and antibody obtained by the method |
| 12/24/2008 | WO2008155999A1 Gabaergic neuron activator |
| 12/24/2008 | WO2008155998A1 Antianxiety/antidepressant agent |
| 12/24/2008 | WO2008155588A1 Sulfonyl-quinoline derivatives |
| 12/24/2008 | WO2008155573A1 Cinnoline compounds for use in the treatment of schizophrenia |
| 12/24/2008 | WO2008155533A2 Phenothiazine compounds for treating mild cognitive impairment |
| 12/24/2008 | WO2008155357A2 Use of dopamine stabilizers |
| 12/24/2008 | WO2008155132A1 Spiro [piperidine-4, 4' -thieno [3, 2-c] pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
| 12/24/2008 | WO2008155000A1 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives |
| 12/24/2008 | WO2008135639A3 Novel useful inhibitors |
| 12/24/2008 | WO2008129529A3 Cannabinoid for the treatment of neuronal damage in diabetic patients |
| 12/24/2008 | WO2008118141A3 Use of cannabinoid modulating compounds in combination with other therapeutic compounds for adjunctive therapy |
| 12/24/2008 | WO2008107481A8 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| 12/24/2008 | WO2008097503A3 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
| 12/24/2008 | WO2008076685A3 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 12/24/2008 | WO2008060617A3 Therapeutic uses of tim-3 modulators |
| 12/24/2008 | WO2008060372A3 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 12/24/2008 | WO2008021463A3 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 12/24/2008 | WO2008008553A3 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 12/24/2008 | EP2006382A1 Dopamine-producing neuron progenitor cell marker 187a5 |
| 12/24/2008 | EP2006303A1 Recombinant antibodies specific for Beta-Amyloid ends, DNA encoding and methods of use thereof |
| 12/24/2008 | EP2005956A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical |
| 12/24/2008 | EP2005951A2 Agent for improving nervous system cell functions |
| 12/24/2008 | EP2004823A2 Treatment of cns conditions |
| 12/24/2008 | EP2004694A2 Methods for preventing and treating amyloidogenic diseases |
| 12/24/2008 | EP2004692A1 Treatment of multiple sclerosis and/or rheumatoid arthritis |
| 12/24/2008 | EP2004688A1 Improved protofibril selective antibodies and the use thereof |
| 12/24/2008 | EP2004672A2 A process for concentration of a polypeptide |
| 12/24/2008 | EP2004659A1 Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/24/2008 | EP2004645A2 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 12/24/2008 | EP2004630A1 2-aminopyrimidin-4-ones and their use for treating or preventing a -related pathologies |
| 12/24/2008 | EP2004624A1 Novel bi-aryl amines |
| 12/24/2008 | EP2004613A2 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators |
| 12/24/2008 | EP2004605A1 Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists |
| 12/24/2008 | EP2004591A1 Cyclopropanes with central nervous system activity |
| 12/24/2008 | EP2004212A1 Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
| 12/24/2008 | EP2004211A1 Dosing regimes for lh or hcg and epo for treatment of neurological disorders |
| 12/24/2008 | EP2004204A1 Treatment of neurodegenerative diseases |
| 12/24/2008 | EP2004195A1 Use of 5h-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders |
| 12/24/2008 | EP2004191A1 Trimetazidine for use in the treatment of fibromyalgia syndrome and related conditions |
| 12/24/2008 | EP2004186A2 Varenicline standards and impurity controls |
| 12/24/2008 | EP2004179A1 Medicament, cosmetic or food product comprising an indol compound, the use thereof and the method of isolation thereof from sauerkraut |
| 12/24/2008 | EP2004155A1 Inhibitors of protein aggregation |
| 12/24/2008 | EP2004139A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment |
| 12/24/2008 | EP1917267B1 Crystal form of asenapine maleate |
| 12/24/2008 | EP1805169B1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses |
| 12/24/2008 | EP1687314B1 PREPARATION OF 1-AZA-2-OXA-DIBENZO [e,h] AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 12/24/2008 | EP1633756B1 A2a adenosine receptor antagonists |
| 12/24/2008 | EP1553952B1 Use of dihydroimidazolones for the treatment of epilepsy in dogs |
| 12/24/2008 | EP1534508B1 Embossable and writable multilaminate backing construction |
| 12/24/2008 | EP1501503B1 Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatment of central nervous system disturbances |
| 12/24/2008 | EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 12/24/2008 | EP1373206B1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 12/24/2008 | EP1341786B1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 12/24/2008 | EP1218511B1 Antimicrobial compositions |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | DE102007028198A1 New alkyl-ketone compounds are histone deacetylase inhibitors, useful to treat e.g. cancer, hematologic or solid tumors, non-Hodgkins tumors, T-cell lymphoma, type I diabetes or Hashimoto's thyroiditis, and to modulate e.g. cell cycle |
| 12/24/2008 | CN101331143A Hypophosphorous acid derivatives and their therapeutical applications |
| 12/24/2008 | CN101331132A [ (1H- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenrative disorders |
| 12/24/2008 | CN101330923A 治疗性疫苗 Therapeutic vaccine |
| 12/24/2008 | CN101330915A Pharmaceutical compositions containing Erythrine mulungu derivatives and processes for their production |
| 12/24/2008 | CN101330907A Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
| 12/24/2008 | CN101328221A Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
| 12/24/2008 | CN101328196A Process for obtaining pure monosialoganglioside GM1 for medical use |
| 12/24/2008 | CN101328174A Method for preparing 3-(2-chloroethyl)-2-methyl-4H- naphthyridine[1,2-a]pyrimidine-4-ketone |
| 12/24/2008 | CN101328173A Method for preparing 6-fluoro-3-(4- piperidyl)-1,2-benzo isoxazole hydrochlorate |
| 12/24/2008 | CN101328172A 4-substituted 2,7-phthalazine compound, and preparation and usethereof |
| 12/24/2008 | CN101328166A 2-dihydroindole ketone derivate as protein kinase inhibitor and histone deacetylase inhibitor |
| 12/24/2008 | CN101328151A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/24/2008 | CN101328117A 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 12/24/2008 | CN101327301A Pharmaceutical combination for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327300A Pharmaceutical combination for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327299A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 12/24/2008 | CN101327297A Chinese medicine composition for treating insomnia |
| 12/24/2008 | CN101327296A Compound Chinese medicine preparation for treating and improving insomnia and preparation method thereof |
| 12/24/2008 | CN101327292A Pharmaceutical combination for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327291A Pharmaceutical combination for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327290A Pharmaceutical combination for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327289A Novel uses of day lily and day lily total flavones |
| 12/24/2008 | CN101327285A Pharmaceutical combination for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327281A Chinese medicine for treating palsy facial paralysis |
| 12/24/2008 | CN101327262A Qingkailing suppositorium |
| 12/24/2008 | CN101327251A Pharmaceutical combination for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327248A Chinese medicine for treating epilepsy acute attack using Chinese medicine inhalation method |
| 12/24/2008 | CN101327243A Pharmaceutical combination for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327240A Pharmaceutical combination for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327239A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory |
| 12/24/2008 | CN101327209A Dihydromyricetin injection, powder injection and preparation method thereof |
| 12/24/2008 | CN101327196A Dosage form and method for administering drug |
| 12/24/2008 | CN101327184A Solid preparation containing diphenhydramine |
| 12/24/2008 | CN101327010A Method for preparing amber ginseng |
| 12/24/2008 | CN101326949A Chewing gum instead of tobacco |
| 12/24/2008 | CN101326945A Jujube chestnut leaf tea |
| 12/24/2008 | CN100445295C 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 12/24/2008 | CN100445285C Nicotinic acetylcholine receptor ligands |
| 12/24/2008 | CN100445268C Process of extracting huperzine B from plant medicine material huperzine serrate |